Table 2 Patient’s clinical symptoms before colchicine therapy
From: A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever
Population n (%) | Group Ia n (%) | Group IIb n (%) | p values ¥ | |
|---|---|---|---|---|
Data available | 45 (88%) | 22 (79%) | 23 (100%) | |
Fever | 44 (83%) | 21 (70%) | 23 (100%) | 0.3 |
Abdominal pain | 33 (73%) | 20 (91%) | 13 (57%) | 0.009 |
Arthralgia | 21 (41%) | 11 (39%) | 10 (44%) | 0.494 |
Asthenia | 2 (4%) | 1 (4%) | 1 (5%) | 0.974 |
Myalgia | 8 (18%) | 2 (9%) | 6 (26%) | 0.136 |
Thoracic pain | 10 (22%) | 6 (27%) | 4 (17%) | 0.4 |
Diarrhoea | 2 (4%) | 1 (5%) | 1 (4%) | 0.974 |
Amyloidosis | 1 (2%) | 1 (5%) | 0 (0%) | 0.301 |
Skin rash | 15 (33%) | 8 (36%) | 7 (30%) | 0.673 |
Arthritis | 6 (13%) | 4 (18%) | 2 (9%) | 0.349 |
Peritonitis | 8 (18%) | 2 (9%) | 6 (26%) | 0.14 |
Vomiting | 2 (4%) | 1 (5%) | 1 (4%) | 0.974 |
Headache | 3 (7%) | 0 (0%) | 3 (13%) | 0.08 |